Labcorp Agrees to Acquire BioReference Health Assets for $722 Million
Labcorp agreed to acquire select assets of BioReference Health, a subsidiary of OPKO Health, for $722 million in cash at closing.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
3 results loaded, newest first. End of these results.
Labcorp Agrees to Acquire Select BioReference Health Assets
Labcorp entered into an agreement with OPKO Health to acquire select assets of BioReference Health.
Labcorp agrees to buy select BioReference Health assets for $722 million plus earnout
Labcorp agreed to acquire select BioReference Health assets from OPKO Health for $722 million cash, subject to closing revenue adjustments. The deal includes the 4Kscore prostate cancer test, with up to $150 million in additional earnout payments tied to test revenue. Acquired assets include clinical and specialty test